-
08
2021
Caliway awarded patents for CBL-514 in the major market countries
CBL-514 has obtained more than 30 patents in major markets, including the United States, Europe, Canada, Australia, Taiwan, South Korea, Singapore, Russia and Mexico, etc.
-
05
2021
The phase IIa of CBL-514 injection was completed
Caliway announced the innovative abdominal fat reduction drug CBL-514 to meet primary and secondary endpoints in Phase IIa study.
